Expertise in
21
conditions

Chang A. Shu

139 Middle Renmin Road, 
Changsha, CN 
Expertise in
21
conditions
139 Middle Renmin Road, 
Changsha, CN 

Overview

Chang Shu practices practicing medicine in Changsha, China.

Mr. Shu is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Aortic Dissection, Thoracic Aortic Aneurysm, Aberrant Subclavian Artery, Aneurysm Repair, and Angioplasty.

He is actively involved in clinical research, co-authoring 794 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

139 Middle Renmin Road, Changsha, 410011, China
Other Locations
Peking Union Medical College Hospital, Peking Union Medical College, Beijing, China
126 Xinmin Street, Changchun, 130021, China
1095 Jie Fang Avenue, Wuhan, 430030, China
17 Qinghuadonglu Road, Beijing, 100083, China
238 Jiefang Road, Wuhan, 430060, China
68 Changle Road, Nanjing, 210006, China
69 Xijunyuan Road, Xi'an, 710002, China
Hangkong Road 13, Wuhan, China
193 Tunxi Road, Hefei, 230009, China
Central South University 139 Renmin Middle Road, Changsha, 410011, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Prospective Study for Aortic Arch Therapy With stENt-graft for Chimney technologY：A Prospective, Multi-center, Objective Performance Criteria Clinical Trial
Prospective Study for Aortic Arch Therapy With stENt-graft for Chimney technologY：A Prospective, Multi-center, Objective Performance Criteria Clinical Trial
Enrollment Status: Completed
Publish Date: June 18, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of NL003 in Subject With Critical Limb Ischemia（Rutherford 5）
A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of NL003 in Subject With Critical Limb Ischemia（Rutherford 5）
Enrollment Status: Completed
Publish Date: September 20, 2024
Intervention Type: Genetic, Other
Study Drug: NL003 Hepatocyte Growth Factor cDNA Hybrid
Study Phase: Phase 3
A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of NL003 in Subject With Critical Limb Ischemia(Rutherford 4)
A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of NL003 in Subject With Critical Limb Ischemia(Rutherford 4)
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Genetic, Other
Study Drug: NL003 Hepatocyte Growth Factor-X7 cDNA Hybrid
Study Phase: Phase 3
Efficacy and Safety of Alprostadil Liposomes for Injection in the Treatment of Atherosclerotic Occlusive Disease of the Lower Extremities-A Phase II Multi-center Randomised Controlled Trial
Efficacy and Safety of Alprostadil Liposomes for Injection in the Treatment of Atherosclerotic Occlusive Disease of the Lower Extremities-A Phase II Multi-center Randomised Controlled Trial
Enrollment Status: Unknown
Publish Date: March 10, 2017
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

794 Total Publications

Safety and Efficacy Evaluation of a Novel High-Frequency Automated-Pullback Peripheral Intravascular Ultrasound System in a Porcine Model.
Safety and Efficacy Evaluation of a Novel High-Frequency Automated-Pullback Peripheral Intravascular Ultrasound System in a Porcine Model.
Journal: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists
Published: September 04, 2026

Frequently Asked Questions about Chang A. Shu

Is Chang A. Shu a top-rated expert for Aortic Dissection?

MediFind is an objective health platform that identifies experts based on real-world data. Chang A. Shu is classified as an Elite expert for Aortic Dissection, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Chang A. Shu participate in research or clinical trials?

Yes. Chang A. Shu has published 794 articles and abstracts on conditions like Aortic Dissection. You can view a list of Chang A. Shu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Shu's expertise for a condition
ConditionClose
View All 17 Advanced Conditions
View All 139 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile